Sylimarol 70mg (30 Tablets)
The drug Sylimarol 70mg is used as an adjuvant in dysfunction and liver damage. Contains milk thistle husk extract.
It is used as an auxiliary in convalescence after toxic and metabolic liver damage caused, among others, by toxic factors (e.g. alcohol, pesticides) and indigestion (flatulence, belching) after eating hard-to-digest food. Supportive in ailments after acute and chronic liver diseases.
Active substance: Silybi mariani fructus
100 mg of dry milk thistle husk extract (Silybi mariani fructus extractum siccum).
Adults and adolescents over 12 years of age: 1 tablet 3 times a day after eating, unless your doctor tells you otherwise. The drug requires systematic use for 2-4 weeks until the 6-month treatment. The time of use of the drug should be consulted with the doctor. After consulting a doctor and after more serious poisoning, the dose may be increased to 5 tablets a day. The minimum daily dose is 200 mg and the maximum 400 mg of silymarin.
Use of the drug in children and adolescents
Due to the lack of safety data, the drug is not recommended for use in children under 12 years of age.
Hypersensitivity to any of the components or plants of the Compositae / Asteraceae family. The use of silymarin in children has not been studied, therefore its use in children under 12 years of age is not recommended.
In the event of an intolerance to certain sugars, consult a physician before taking this product.
Store at a temperature below 25°C.
Keep out of the reach and sight of children.
Do not use Sylimarol 70 mg after the expiry date stated on the packaging.
Medicines should not be disposed of via wastewater or household waste. Ask the pharmacist how to dispose of medicines no longer needed. Such behavior will help to protect the environment.
The drug Sylimarol 70mg is in the form of sugar-coated tablets. The available packaging contains 30 tablets in an Al / PVC blister and in a carton.
The drug should not be recommended for the treatment of acute poisoning.
Avoid substances that are harmful to the liver during treatment.
Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this product.
Pregnancy and lactation
Due to the lack of safety data, the preparation should not be used during pregnancy and breastfeeding.
The preparation does not affect the ability to drive vehicles and operate moving mechanisms.
Overdose symptoms are unknown.
Interactions with other drugs
So far, no interactions with other drugs have been reported.
Mild laxative effects and other transient mild gastrointestinal disturbances may occur during use. The frequency of these symptoms has not been established.